Mesenchymal stem cell therapy for premature ovarian insufficiency: progress and challenges
Abstract Premature ovarian insufficiency (POI), particularly chemotherapy-induced ovarian failure (CIOF), severely compromises the reproductive and endocrine health of young women. Current fertility-preserving strategies, such as cryopreservation and hormone therapy, fail to restore endogenous ovari...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMC
2026-02-01
|
| Collection: | Journal of Ovarian Research |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1186/s13048-026-01976-4 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
